Cargando…

1811. Minimizing Time to Optimal Therapy for Enterobacteriaceae Bloodstream Infections: Is Organism Identification Enough?

BACKGROUND: BSI due to ceftriaxone (CRO)-resistant ENT are increasing in frequency, and are associated with delays in time to appropriate therapy. However, treating all patients at risk for CRO-resistant organisms with empiric carbapenem (CARB) therapy risks over exposure. Strategies are needed to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cwengros, Laura N, Mynatt, Ryan P, Timbrook, Tristan T, Pogue, Jason M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253648/ http://dx.doi.org/10.1093/ofid/ofy210.1467

Ejemplares similares

Minimizing Time to Optimal Antimicrobial Therapy for Enterobacteriaceae Bloodstream Infections: A Retrospective, Hypothetical Application of Predictive Scoring Tools vs Rapid Diagnostics Tests
por: Cwengros, Laura N, et al.
Publicado: (2020)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

1596. Impact of Vancomycin Area Under Curve on Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Alosaimy, Sara, et al.
Publicado: (2019)

2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Impact of Multidrug-resistant Enterobacteriaceae Bloodstream Infections in Children
por: Aizawa, Yuta, et al.
Publicado: (2017)

2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negative (GN) Bacteremia
por: Tran, Kieu-Nhi, et al.
Publicado: (2019)

848. Low-Bioavailability vs. High-Bioavailability Oral Antibiotics for the Definitive Treatment of Enterobacteriaceae Bacteremia from Suspected Urine Source in Hospitalized Veterans
por: Sutton, Jesse D, et al.
Publicado: (2019)

284. Evaluation of Oral Step-Down Therapy for Enterobacteriaceae Bloodstream Infection
por: Utley, Sara, et al.
Publicado: (2020)

167. Clinical Impact of Rapid Multiplex Polymerase Chain Reaction-Based Diagnostic Testing for Hospitalized Patients with Bloodstream Infections (BSIs) in a National Cohort of Veterans Affairs Patients
por: Britt, Nicholas, et al.
Publicado: (2022)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

Predicting Extended-Spectrum Beta-Lactamase and Carbapenem Resistance in Enterobacteriaceae Bacteremia: A Diagnostic Model Systematic Review and Meta-Analysis
por: Timbrook, Tristan T., et al.
Publicado: (2023)

Gram-Negative Polymicrobial Bloodstream Infections and Clinical Decision Making with a Microarray Testing System
por: Claeys, Kimberly, et al.
Publicado: (2017)

1811. Impact of a one-time oritavancin infusion on hospital length of stay for uncomplicated skin and soft tissue infections
por: Bremmer, Derek N, et al.
Publicado: (2023)

Evariste Galois 1811–1832
por: Rigatelli, Laura Toti
Publicado: (1996)

Identification, classification and evolution of Owl Monkeys (Aotus, Illiger 1811)
por: Menezes, Albert N, et al.
Publicado: (2010)

Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: a Patient-level Analysis of Published Data
por: O’Donnell, J Nicholas, et al.
Publicado: (2017)

México-Cádiz 1811 : Un documento y un debate /
por: Calvillo, Manuel
Publicado: (1989)

Hospital-acquired enterobacteriaceae Bloodstream Infections in Children
por: Kłos, Marta, et al.
Publicado: (2019)

2800. Carbapenem Resistant Enterobacteriaceae bloodstream infections in children from Latin America & Caribbean region: systematic review and meta-analysis
por: Ruvinsky, Silvina, et al.
Publicado: (2023)

2075. The Hypothetical Impact of Accelerate Pheno on Time to Appropriate Therapy (TTAT) and Time to Optimal Therapy (TTOT) in an Institution with an Established Antimicrobial Stewardship Program and Rapid Genotypic Organism/Resistance Marker Identification
por: Cooper, Christopher, et al.
Publicado: (2018)

570. Impact of a Blood Culture Direct Identification Procedure on Time to Identification for Gram-Negative Organisms and Antimicrobial Management in Bloodstream Infections
por: Coppinger, Corwin, et al.
Publicado: (2023)

1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)
por: Timbrook, Tristan T, et al.
Publicado: (2018)

Cartas de un americano, 1811-12 /
por: Mier Servando Teresa de, 1765-1827
Publicado: (1976)

2193. Factors Impacting the Duration of Antimicrobial Therapy for Community-Acquired Pneumonia
por: Sandhu, Avnish, et al.
Publicado: (2019)

1185. Impact of Utilizing Drug Resistance in Pneumonia (DRIP) Score on Management of Pneumonia
por: Sandhu, Avnish, et al.
Publicado: (2019)

Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping
por: Caffrey, Aisling R., et al.
Publicado: (2019)

2375. Skin and Soft-Tissue Infections in Patients With Obesity or Heart Failure
por: Ihm, Claudia, et al.
Publicado: (2018)

128. Validation of a rapid diagnostics platform for detecting extended-spectrum beta-lactamase resistance in gram negative bacteremia
por: Andrews, Sam, et al.
Publicado: (2023)

168. Closing Time: A Quasi-experiment Comparing Time to Optimal Therapy using Traditional Identification and Susceptibility Methods, Rapid Identification, or Rapid Identification with Phenotype for Gram-negative Bloodstream Infections
por: Perry, Rachel, et al.
Publicado: (2022)

2098. Reduction of Central-Line-associated Bloodstream Infection Rates: Impact of Minimizing Blood Cultures from Central Lines
por: Murad, Nisreen, et al.
Publicado: (2018)

1964. Microbiological Outcomes With Plazomicin (PLZ) vs. Colistin (CST) in Patients With Bloodstream Infections (BSI) Caused by Carbapenem-Resistant Enterobacteriaceae (CRE) in the CARE Study
por: Serio, Alisa W, et al.
Publicado: (2018)

55. Impact of Testing Methodology and Reporting on Time to Preferred Antibiotic Therapy in Extended Spectrum Beta-Lactamase producing Enterobacteriaceae (ESBL-E) Bloodstream Infections
por: Bui, Hanh, et al.
Publicado: (2021)

912. Impact of Rapid Identification and Stewardship Intervention on Coagulase-negative Staphylococcus Bloodstream Infection (BSI)
por: Goshorn, Eli S, et al.
Publicado: (2022)

642. Facility Reported vs. CLSI MIC Breakpoint Comparison of Carbapenem Non-susceptible (Carb-NS) Enterobacteriaceae (ENT) from 2016-2019: A Multicenter Evaluation
por: Gupta, Vikas, et al.
Publicado: (2021)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

524. The Journey to Implement a Computerized Clinical Decision Support (CDS) Tool to Improve Testing for Clostridium difficile Infection (CDI)
por: Mayer, Jeanmarie, et al.
Publicado: (2018)

Cartas a un comerciante español 1811-1817
por: Lerdo de Tejada, Juan Antonio, -1829
Publicado: (1989)

Cartas a un comerciante español 1811-1817
por: Lerdo de Tejada, Juan Antonio, et al.
Publicado: (2018)

Sir James Young Simpson and Chloroform (1811—1870)
Publicado: (1898)

Cannot write session to /tmp/vufind_sessions/sess_k2hl1io1jap4smfj07a3k588np